SUB: Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments.–reg.
X X X X Extracts X X X X
X X X X Extracts X X X X
....;ाराष्ट्र -400707 F.No.S/12-Gen-07/2018-19 AM(X) Date:13.04.2018 PUBLIC NOTICE NO. 58/2018 SUB: Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments.-reg. ******** Attention of the Exporters, Custom Brokers and all concerned is invited to the Notice No.52/2015-2020 dated 05.01.2016 issued by the DGFT on the above subject as amended by Public notice No. 03/2015-2020 dated 21.04.2016 (copies enclosed). 2. As per the aforesaid notice, all drugs manufactured by Non-SSI units with manufacturing date on or after 01.04.2016 and all drugs manufactured by SSI units with manufacturing date on or after 01.04.2017 can be exported only if both tertia....
X X X X Extracts X X X X
X X X X Extracts X X X X
....All Manufacturers (SSI & Non- SSI Manufacturers): As one time exemption all manufacturers are exempted from maintenance of parent-child relationship in packaging and its uploading on central portal (http://dava.gov.in) till 31.03.2016. However, the requirements of printing of barcoding on the different levels or packaging will be applicable as prescribed. b) Extended Date of Exemption to SSI Manufacturers: All SSI drug manufacturers are exempted from requirement of maintaining Parent- Child relationship in packaging levels for a further period up to 31.03.2017. However, they are required to upload Tertiary level data on the central portal mandatorily as prescribed in public notice no. 1312015-2020 dated 22.05.2015. iii. The data me....
X X X X Extracts X X X X
X X X X Extracts X X X X
....17 are exempted from requirement of data uploading on Central Portal. vii. All drugs manufactured by non SSI units with manufacturing date on or after 01.04.2016 and all drug manufactured by SSI units with manufacturing date on or after 01 .04.2017 can be exported only if both tertiary and secondary packaging carry barcoding as applicable and the relevant data as prescribed by DGFT is uploaded on the Central Portal. Explanation: (a) For the purpose of this rule, (i) Drug formulation means a formulation manufactured with a license from Drug Control Authority under the provisions of Drugs & Cosmetics Act and Rules made there under and registered as "Drug" with the FDA of importing country. (ii) Primary packaging means....